Tumor of Pancreas Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Tumor of Pancreas clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Carcinoid TumorCarcinoid Tumor of PancreasCarcinoid Tumor of Liver+6 more
Crinetics Pharmaceuticals Inc.141 enrolled43 locationsNCT07087054
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Not Applicable

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Pancreatic CancerPancreas CancerAdenocarcinoma of the Pancreas+1 more
HistoSonics, Inc.50 enrolled1 locationNCT06282809
Recruiting
Not Applicable

Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

Tumor of PancreasSurgical Blood Loss
Zhejiang University30 enrolled1 locationNCT06164769
Recruiting
Not Applicable

Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors

Neuroendocrine Tumor Grade 1Neuroendocrine Tumor of Pancreas (Disorder)
Institut Paoli-Calmettes82 enrolled1 locationNCT04520932
Recruiting
Not Applicable

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

Multiple Endocrine Neoplasia Type 1Neuroendocrine Tumor of Pancreas
J.M. de Laat20 enrolled1 locationNCT05037461
Recruiting

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine NeoplasmParagangliomaPheochromocytoma+23 more
Universidad Nacional Autonoma de Mexico750 enrolled3 locationsNCT06523582
Recruiting
Phase 2

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Neuroendocrine TumorsProgressionNeuroendocrine Tumor of Pancreas+4 more
AC Camargo Cancer Center100 enrolled2 locationsNCT06472388